The use of ferric maltol compositions for the treatment or prevention of cancer and tumours is disclosed, in particular for the treatment or prevention of gastrointestinal cancers or gastrointestinal tumours, such as large bowel (colorectal), small bowel or upper gastrointestinal cancers.

The present invention relates to a solid oral dosage form comprising an extended-release tablet core that is coated with an immediate-release coating, wherein said extended-release tablet core comprises at least one vitamin B12 depleting drug, and wherein said immediate-release coating comprises vitamin B12 or a spray dried formulation thereof. In a preferred embodiment, the vitamin B12 depleting drug is metformin or a pharmaceutically acceptable salt thereof.

The present invention concerns a food composition comprising at least one of fiber, beta-carotene, folate, magnesium, zinc, vitamin C, and thiamin, for use in assisting in post-partum weight management.

The present invention concerns a food composition comprising at least one of fiber, beta-carotene, folate, magnesium, zinc, vitamin C, and thiamin, for use in assisting in post-partum weight management.

The invention relates to the use of beta1,3′-galactosyllactose for improving the gut barrier function. This can in particular be administered to subjects at risk for increased gut barrier permeability, preferably infants and young children.

A material which promotes ammonia metabolism in the body, as well as a material which has excellent ammonia metabolism improving effect and is effective for endurance enhancement and anti-fatigue are provided. An ammonia metabolism promoting agent, comprising catechins as an active ingredient. An agent for preventing or ameliorating hyperammonemia, hepatic encephalopathy or chronic fatigue syndrome, comprising catechins compound as an active ingredient. An ammonia metabolism promoting agent, an endurance enhancing agent and an anti-fatigue agent, comprising catechins, citrulline and arginine as active ingredients.

This document provides compositions containing arabinoxylan, methods for making compositions containing arabinoxylan, and methods for using compositions containing arabinoxylan as, for example, a food ingredient, dietary supplement ingredient, or pharmaceutical ingredient. In particular, the document discloses the use of lignocellulosic biomass with water at temperatures and pressures to provide the disclosed products.

This document provides compositions containing arabinoxylan, methods for making compositions containing arabinoxylan, and methods for using compositions containing arabinoxylan as, for example, a food ingredient, dietary supplement ingredient, or pharmaceutical ingredient. In particular, the document discloses the use of lignocellulosic biomass with water at temperatures and pressures to provide the disclosed products.

A health benefiting daily nutrition includes protein, the protein having a protein weight. The health benefiting daily nutrition includes fiber, the fiber having a fiber weight. The fiber weight is more than 5 g. A ratio of [the protein weight]:[the fiber weight]=1:0.5-1.5.

An orally deliverable dosage system comprises (a) iron in a form of one or more physiologically acceptable iron grades, compounds and/or complexes; and (b) an agent to mitigate one or more gastrointestinal adverse effects of unabsorbed iron, said agent comprising one or both of a zinc component and a chelator component, said zinc component if present comprising one or more physiologically acceptable zinc compounds and/or complexes, and said chelator component if present comprising an ion-chelating compound formulated for release distal to the primary site of iron absorption in the duodenum.